Conventional protein kinase C in the brain: 40 years later
Neuronal Signaling · 2017
DOI: 10.1042/ns20160005 ↗At a glance
Übersichtsarbeit in Neuronal Signaling, 2017. Written by Julia A Callender and 1 co-authors. Institution: Department of Pharmacology, University of California, San Diego, La Jolla, CA 92093-0721, U.S.A. Cited 99 times so far (Crossref); 109 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Protein kinase C (PKC) is a family of enzymes whose members transduce a large variety of cellular signals instigated by the receptor-mediated hydrolysis of membrane phospholipids. While PKC has been widely implicated in the pathology of diseases affecting all areas of physiology including cancer, diabetes, and heart disease—it was discovered, and initially characterized, in the brain. PKC plays a key role in controlling the balance between cell survival and cell death. Its loss of function is generally associated with cancer, whereas its enhanced activity is associated with neurodegeneration. This review presents an overview of signaling by diacylglycerol (DG)-dependent PKC isozymes in the brain, and focuses on the role of the Ca2+-sensitive conventional PKC isozymes in neurodegeneration.
Subjects
Author keywords
Authors and institutions
- Department of Pharmacology, University of California, San Diego, La Jolla, CA 92093-0721, U.S.A.
- Biomedical Sciences Graduate Program, University of California, San Diego, La Jolla, CA 92093-0721, U.S.A.
Cite
APA
Callender, J. A., & Newton, A. C. (2017). Conventional protein kinase C in the brain: 40 years later. Neuronal Signaling. https://doi.org/10.1042/ns20160005
Vancouver
Callender JA, Newton AC. Conventional protein kinase C in the brain: 40 years later. Neuronal Signaling. 2017. doi:10.1042/ns20160005
BibTeX
@article{Callender2017,
author = {Callender, Julia A and Newton, Alexandra C},
title = {Conventional protein kinase C in the brain: 40 years later},
journal = {Neuronal Signaling},
year = {2017},
doi = {10.1042/ns20160005}
}
EUVIMED